换一批
换一批The effect of oral immunomodulatory therapy on treatment uptake and persistence in multiple sclerosis.
作者：
Matthew,Warrender-Sparkes [1]
;
Tim,Spelman [2]
;
Guillermo,Izquierdo [3]
;
Maria,Trojano [4]
;
Alessandra,Lugaresi [5]
;
François,Grand'Maison [6]
;
Eva,Havrdova [7]
;
Dana,Horakova [7]
;
Cavit,Boz [8]
;
Celia,Oreja-Guevara [9]
;
Raed,Alroughani [10]
;
Gerardo,Iuliano [11]
;
Pierre,Duquette [12]
;
Marc,Girard [12]
;
Murat,Terzi [13]
;
Raymond,Hupperts [14]
;
Pierre,Grammond [15]
;
Thor,Petersen [16]
;
Ricardo,Fernandez-Bolaños [17]
;
Marcela,Fiol [18]
;
Eugenio,Pucci [19]
;
Jeannette,Lechner-Scott [20]
;
Freek,Verheul [21]
;
Edgardo,Cristiano [22]
;
Vincent,Van Pesch [23]
;
Tatjana,Petkovska-Boskova [24]
;
Fraser,Moore [25]
;
Ilya,Kister [26]
;
Roberto,Bergamaschi [27]
;
Maria Laura,Saladino [28]
;
Mark,Slee [29]
;
Michael,Barnett [30]
;
Maria Pia,Amato [31]
;
Cameron,Shaw [32]
;
Neil,Shuey [33]
;
Carolyn,Young [34]
;
Orla,Gray [35]
;
Ludwig,Kappos [36]
;
Helmut,Butzkueven [37]
;
Tomas,Kalincik [38]
;
Vilija,Jokubaitis [39]
;
MSBase study group
作者单位：
Department of Medicine, University of Melbourne, Melbourne, Australia.
[1]
Department of Neurology, Royal Melbourne Hospital, Melbourne, Australia.
[2]
Hospital Universitario Virgen Macarena, Sevilla, Spain.
[3]
Department of Basic Medical Sciences, Neuroscience and Sense Organs, University of Bari, Italy.
[4]
MS Center, Department of Neuroscience, Imaging and Clinical Sciences, University 'G. d'Annunzio', Chieti, Italy.
[5]
Neuro Rive-Sud, Hôpital Charles LeMoyne, Quebec, Canada.
[6]
Department of Neurology and Center of Clinical Neuroscience, 1st Faculty of Medicine, General University Hospital and Charles University in Prague, Czech Republic.
[7]
Karadeniz Technical University, Trabzon, Turkey.
[8]
University Hospital San Carlos, IdISSC, Madrid, Spain.
[9]
Amiri Hospital, Kuwait City, Kuwait.
[10]
Ospedali Riuniti di Salerno, Salerno, Italy.
[11]
Hôpital Notre-Dame, Montreal, Canada.
[12]
Ondokuz Mayis Üniversitesi, Samsun, Turkey.
[13]
Orbis Medicle Center, Sittard, The Netherlands.
[14]
Hotel-Dieu de Levis, Quebec, Canada.
[15]
Aarhus University Hospital, Aarhus C, Denmark.
[16]
Hospital Universitario Virgen de Valme, Seville, Spain.
[17]
FLENI, Buenos Aires, Argentina.
[18]
Ospedale di Macerata, Macerata, Italy.
[19]
John Hunter Hospital, Newcastle, Australia.
[20]
Groen Hart Ziekenhuis, Gouda, The Netherlands.
[21]
Hospital Italiano, Buenos Aires, Argentina.
[22]
Cliniques Universitaires Saint-Luc, Brussels, Belgium.
[23]
Neurology Clinical Center, Skopje, Macedonia.
[24]
Jewish General Hospital, Montreal, Canada.
[25]
New York University Langone Medical Center, New York, USA.
[26]
National Neurological Institute C. Mondino, Pavia, Italy.
[27]
INEBA, Buenos Aires, Argentina.
[28]
Flinders University and Medical Centre, Adelaide, Australia.
[29]
Brain and Mind Research Institute, Sydney, Australia.
[30]
Department NEUROFARBA, Section of Neurosciences, University of Florence, Florence, Italy.
[31]
Geelong Hospital, Geelong, Australia.
[32]
St Vincent's Hospital, Melbourne, Australia.
[33]
The Walton Centre for Neurology and Neurosurgery, Liverpool, United Kingdom.
[34]
Craigavon Area Hospital, Portadown, United Kingdom.
[35]
University Hospital Basel, Neurology, Departments of Medicine, Clinical Research and Biomedicine, Basel, Switzerland.
[36]
Department of Medicine, University of Melbourne, Melbourne, Australia/ Department of Neurology, Box Hill Hospital, Monash University, Box Hill, Australia.
[37]
Department of Medicine, University of Melbourne, Melbourne, Australia/Department of Neurology, Royal Melbourne Hospital, Melbourne, Australia.
[38]
Department of Medicine, University of Melbourne, Melbourne, Australia vilija.jokubaitis@unimelb.edu.au.
[39]
主题词
投药, 口服(Administration, Oral);成年人(Adult);老年人(Aged);脱髓鞘疾病(Demyelinating Diseases);药物替代(Drug Substitution);女(雌)性(Female);人类(Humans);免疫抑制剂(Immunosuppressive Agents);Kaplan-Meiers评估(Kaplan-Meier Estimate);男(雄)性(Male);服药依从性(Medication Adherence);中年人(Middle Aged);多发性硬化, 复发缓解性(Multiple Sclerosis, Relapsing-Remitting);多元分析(Multivariate Analysis);比例危险度模型(Proportional Hazards Models);前瞻性研究(Prospective Studies);登记(Registries);危险因素(Risk Factors);时间因素(Time Factors);治疗结果(Treatment Outcome)
DOI
10.1177/1352458515594041
PMID
26199347
发布时间
2022-03-17
- 浏览91
Multiple sclerosis (Houndmills, Basingstoke, England)
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文
